Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: Preliminary considerations

International Journal of Biological Markers

Volumn 16, Issue 2, 2001, Pages 126-129

  Merendino, R A ^a   Gangemi, S ^a   Ruello, A ^a   Bene, A ^a   Losi, E ^a   Lonbardo, G ^a   Purello D'Ambrosio, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Breast cancer; IL 18; Serum; sICAM 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; LIVER METASTASIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM; TH1 CELL; TUMOR SUPPRESSOR GENE;

EID: 0034873384     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080101600207     Document Type: Article

References (20)

1. IL-18 and IL-18 receptor
2. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family
3. IFN-γ inducing factor/IL-18 administration mediates IFN-γ and IL-12-independent anti-tumor effects
4. In vivo antitumor effects of murine interferon-gamma-inducing factor/interluekin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
5. IL-18 acts as an angiogenesis and tumor suppressor
6. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium
7. Adhesion molecules and tumor metastasis: An update
8. Interleukin-18/interferon gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells
9. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia
10. The significance of soluble interleukin-2, soluble IL-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients
11. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation
12. The effect of serum on NK cell activity
13. Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma
14. Influence of sera from patients affected by neoplasia on some human macrophage functions
15. In vitro effect of lithium chloride on interleukin-15 production by monocytes from breast cancer patients
16. In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients
17. Differential levels of soluble intercellular adhesion molecule-1 (slCAM-1) in early breast cancer and benign breast lesions
18. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast and prognosis: Correlations with clinicopathological features and prognosis
19. Expression and shedding of ICAM-1 in bladder cancer and immunontherapy